ERS/WHO Tuberculosis Consilium: Reporting of the initial 10 cases

European Respiratory Journal

Volumn 43, Issue 1, 2014, Pages 286-289

  D'Ambrosio, Lia ^a   Tadolini, Marina ^b   Dupasquier, Stephane ^c   Tiberi, Simon ^d   Centis, Rosella ^a   Dara, Masoud ^a   Blasi, Francesco ^e   Migliori, Giovanni Battista ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c European Respiratory Society   (Switzerland)

^d IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

BACTERIAL STRAIN; CACHEXIA; CLINICAL EFFECTIVENESS; DIAGNOSTIC TEST; DISEASE SURVEILLANCE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ERADICATION THERAPY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; HUMAN; LETTER; MEDICAL EXPERT; MEDICAL SOCIETY; MULTIDRUG RESISTANT TUBERCULOSIS; MUSCLE ATROPHY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PANDEMIC; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RADIODIAGNOSIS; RELAPSE; TREATMENT DURATION; TUBERCULOSIS CONTROL; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; ADVISORY COMMITTEES; CHILD; EUROPE; FEMALE; HUMANS; MALE; PULMONARY MEDICINE; REFERRAL AND CONSULTATION; SOCIETIES, MEDICAL; TUBERCULOSIS, MULTIDRUG-RESISTANT; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 84891953621     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00125813     Document Type: Letter

References (10)

1. Blasi F, Dara M, van der Werf MJ, et al. Supporting TB clinicians managing difficult cases: The ERS/WHO Consilium. Eur Respir J 2013; 41: 491-494.
2. Blasi F, Barnes PJ, Gaga M, et al. Future directions for the ERS: Presidential plans. Eur Respir J 2013; 42: 875-880.
3. World Health Organization. Global Tuberculosis Report 2012. Geneva, WHO Press, 2012. Available from: www.who.int/tb/publications/global-report/gtbr12- main.pdf.
4. Migliori GB, Dara M, de Colombani P, et al. Multidrug-resistant tuberculosis in Eastern Europe: Still on the increase Eur Respir J 2012; 39: 1290-1291.
5. Skrahina A, Hurevich H, Zalutskaya A, et al. Alarming levels of drug-resistant tuberculosis in Belarus: Results of a survey in Minsk. Eur Respir J 2012; 39: 1425-1431.
6. Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: Impact on multidrug-resistant TB outcomes. Eur Respir J 2013; 42: 156-168.
7. Migliori GB, Sotgiu G, Gandhi NR, et al. Drug resistance beyond extensively drug-resistant tuberculosis: Individual patient data meta-analysis. Eur Respir J 2013; 42: 169-179.
8. Diel R, Rutz S, Castell S, et al. Tuberculosis: Cost of illness in Germany. Eur Respir J 2012; 40: 143-151.
9. Falzon D, Jaramillo E, Schunemann HJ, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38: 516-528.
10. Migliori GB, Zellweger JP, Abubakar I, et al. European Union standards for tuberculosis care. Eur Respir J 2012; 39: 807-819.